Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study.
Minicozzi P, Vicentini M, Innos K, Castro C, Guevara M, Stracci F, Carmona-Garcia M, Rodriguez-Barranco M, Vanschoenbeek K, Rapiti E, Katalinic A, Marcos-Gragera R, Van Eycken L, Sánchez MJ, Bielska-Lasota M, Rossi PG, Sant M; European HR Working Group on colorectal cancer.
Minicozzi P, et al.
Eur J Surg Oncol. 2020 Jun;46(6):1151-1159. doi: 10.1016/j.ejso.2020.02.023. Epub 2020 Feb 21.
Eur J Surg Oncol. 2020.
PMID: 32147427